N/A N=284 Southwest Hub for American Indian Youth Suicide Prevention Research
Suicide · Surveillance · Mental Health
Primary: Suicide Ideation Questionnaire (SIQ) — 10.2; 10; 10.1; 10.1 Z-score
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=202 Affective Social Buffering
Social Stress · Adolescent Behavior
Primary: Cortisol AUCi — -93.6397; -68.0959; -106.9105 (ug/dL)*minutes
Phase 2 N=121 Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis
Primary: Number of Participants With Treatment Emergent Adverse Events — 21; 10; 16; 15 Participants
Phase 1 N=83 Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B
Chronic Hepatitis B
Primary: Percentage of Participants With Treatment-emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) — 100.0; 100.0; 100.0; 100.0 percentage of participants
N/A N=45 Clotild® Smart Guidewire System (CSGS) Evaluation in EndovascUlar Thrombectomy Procedure
Stroke
Primary: The Proportion of Patients Having Intracranial Vessel Perforation and / or Dissection Due to Clotild® Usage at the Site of Usage in Intracranial Vessels — 0 Participants
Phase 1 N=25 The CHILD Trial: Hypoplastic Left Heart Syndrome Study.
Hypoplastic Left Heart Syndrome
Primary: Number of Incidence of Treatment Related Major Adverse Cardiac Events — 1; 0; 6 Events
N/A N=60 Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study
Non-Alcoholic Fatty Liver Disease · Non-Alcoholic Steatohepatitis
Primary: Correlation of the Liver Fat Percentage Reported From MRI-PDFF With Measurements Hepatorenal Index (HRI) of Ultrasound Biomarkers for Liver Fat. — 1.6 Hepatorenal Index
N/A N=21 Self-Care for Dementia Caregivers
Aging · Mental Disorder · Eating, Healthy
Primary: Pre/Post Change in Depressive Symptoms — 2.27 score on a scale
Phase 3 N=1,143 Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring
Contraception
Primary: Contraceptive Efficacy Using the Pearl Index for All Subjects — 2.96 Number of pregnancies per 100 women mths
N/A N=64 The Effect of the Mobile Application Developed for the Care of Sick Newborns
Nursing Caries · Newborn
Primary: Pre-test The Nurse Descriptive Characteristics Form; The Nursing Diagnoses Perception Scale; MissCare Nursing Care Questionnaire in the Neonatal Intensive Care Unit…
Phase 3 N=52 Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
Genital Warts
Primary: Change in the Maximum Size of the Genital Wart Lesion Over the Trial Period (as Measured in mm) — 8; 6; 11; 7 Participants
N/A N=251 Performance and Safety of T2769 in DED
Dry Eye
Primary: Surface Ocular Staining With Fluorescein (With Oxford Scale - Ranges : Minimum 0- Maximum 15) — -2.3; -2.1 score on a scale
Phase 2 N=15 Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis · IPF
Primary: Absolute Change From Baseline in Forced Vital Capacity for 26 Weeks — -0.177; -0.025 Liters
N/A N=200 Evaluating Technologies for Point-of-Care Blood Collections by Patients
Healthy
Primary: Assess the Sample Integrity of Tasso+™ — 23.1; 75.8; 40.5 percentage of samples
N/A N=75 Investigation of the Effects of H-PRF on the Period After Impacted Third Molar Tooth Extraction
Impacted Third Molar Tooth
Primary: Postoperative Facial Swelling (Sum of 3 Linear Distances, mm) — 122.08; 118.55; 116.90; 119.68 Millimeters (mm)